The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study
References
- Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Strok. 2021; 16(2): 217–21. DOI: 10.1177/1747493019897870
- Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease – Double trouble. Med Sci. 2018; 63(1): 30–5. DOI: 10.1016/j.advms.2017.06.005
- Liang F, Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2021; 320(1): H1–H12. DOI: 10.1152/ajpheart.00702.2020
- Borschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases – myocardial infarction and heart failure – a cause for concern. Int J Cardiol. 2019; 287: 162–73. DOI: 10.1016/j.ijcard.2018.11.123
- Costabel JP, Burgos LM, Trivi M. The significance of troponin elevation in atrial fibrillation. J Atr Fibrillation. 2017; 9(6): 1530. DOI: 10.4022/jafib.1530
- Romanov A, Martinek M, Peurerfellner H, Chen S, De Melis M, Grazhdankin I, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction inpatients with preserved left ventricular ejection fraction: Results of the ARREST study. Europace. 2018; 20: 263–70. DOI: 10.1093/europace/euw344
- Andrade JG, Deyell MW, Wong GC, Macle L. Antithrombotic Therapy for Atrial Fibrillation and Coronary Disease Demystified. Can J Cardiol. 2018; 34: 1426–36. DOI: 10.1016/j.cjca.2018.08.028
- Barnes GD. Combining antiplatelet and anticoagulant therapy in cardiovascular disease. Hematology Am Soc Hematol Educ Program. 2020; 2020: 642–8. DOI: 10.1182/hematology.2020000151
- Salam AM. Atrial fibrillation in Middle Eastern Arabs and South Asians: Summary of published articles in the Arabian Gulf. Heart Views. 2019; 20: 158–65. DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_116_19
- Bensahi I, Elouarradi A, Abdeladim S, Elharrass M, Sabry M.
Coronary artery disease in the Arab World . In Laher, I. (eds.), Handbook of Healthcare in the Arab World. Springer: Cham. 2021. pp. 2855–2870. DOI: 10.1007/978-3-030-36811-1_178 - Salam AM, Salim I, Kaddoura R, Singh R, Asaad N, Al-Qahtani A, et al. Hypertension in Middle Eastern Arab and South Asian patients with atrial fibrillation: From a 20-year hospital registry in Qatar (1990–2010). Heart Views. 2021; 22(4): 256–63. DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_33_21
- Ouali S, Ben Halima A, Chabrak S, Chettaoui R, Ben Halima M, Haggui A, et al. Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE-AF). Clin Cardiol. 2021; 44(4): 501–10. DOI: 10.1002/clc.23558
- Shehab A, Zubaid M, Bhagavathula AS, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, et al. Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE). PLoS One. 2017; 12(5):
e0175405 . DOI: 10.1371/journal.pone.0175405 - Azar RR, Ragy HI, Kozan O, El Khuri M, Bazergani N, Marler S, et al. Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program. Int J Cardiol Heart Vasc. 2021; 34: 100763. DOI: 10.1016/j.ijcha.2021.100763
- Al-Makhamreh HK, Al-Sabbagh MQ, Shaban AE, Obiedat AF, Hammoudeh AJ. Prevalence, epidemiological characteristics, and pharmacotherapy of coronary artery disease among patients with atrial fibrillation: Data from Jo-Fib Study. Medicina. 2021; 57(6): 605. DOI: 10.3390/medicina57060605
- Hammoudeh A, Khader Y, Tabbalat R, Badaineh Y, Kadri N, Shawer H, et al. One-year clinical outcome in Middle Eastern patients with atrial fibrillation: The Jordan Atrial Fibrillation (JoFib) Study. Int J Vasc Med. 2022; 2022: 4240999. DOI: 10.1155/2022/4240999
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest. 2010; 137(2): 263–72. DOI: 10.1378/chest.09-1584
- Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010; 138(5): 1093–100. DOI: 10.1378/chest.10-0134
- Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Hemost. 2010; 8: 202–204. DOI: 10.1111/j.1538-7836.2009.03678.x
- Rogalska E, Kuzma Ł, Wojszel ZB, Kurasz A, Napalkov D, Sokolova A, et al. Atrial fibrillation is a predictor of nonobstructive coronary artery disease in elective angiography in old age: a cross-sectional study in Poland and Russia. Aging Clin Exp Res. 2022; 34(1): 175–83. DOI: 10.1007/s40520-021-01895-y
- Allan V, Honarbakhsh S, Casas JP, Wallace J, Hunter R, Schilling R, et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost. 2017; 117(5): 837–50. DOI: 10.1160/TH16-11-0825
- Motloch LJ, Reda S, Larbig R, Wolff A, Motloch KA, Wernly B, et al. Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm. Hellenic J Cardiol. 2017; 58(3): 204–12. DOI: 10.1016/j.hjc.2017.03.001
- De Michieli L, Lobo R, Babuin L, Melduni RM, Iliceto S, Prasad A, et al. Structural cardiac abnormalities in patients with atrial fibrillation/flutter and myocardial injury. Am J Med. 2022; 135(12): 1488–96. e5. DOI: 10.1016/j.amjmed.2022.06.005
- Kea B, Alligood T, Manning V, Raitt M. A review of the relationship of atrial fibrillation and acute coronary syndrome. Curr Emerg Hosp Med Rep. 2016; 4: 107–18. DOI: 10.1007/s40138-016-0105-2
- Nous FMA, Budde RPJ, van Dijkman ED, Musters PJ, Nieman K, Galema TW. Prognostic value of subclinical coronary artery disease in atrial fibrillation patients identified by coronary computed tomography angiography. Am J Cardiol. 2020; 12616–22. DOI: 10.1016/j.amjcard.2020.03.050
- Fanaroff AC, Li S, Marquis-Gravel G, Giri J, Lopes RD, Piccini JP, et al. Atrial fibrillation and coronary artery disease: A long term perspective on the need for combined antithrombotic therapy. Circulation: Circ Cardiovasc Interv. 2021; 14(12):
e011232 . DOI: 10.1161/CIRCINTERVENTIONS.121.011232 - Harskamp RE, Fanaroff AC, Lopes RD, Wojdyla DM, Goodman SG, Thomas LE, et al. Antithrombotic therapy in patients with atrial fibrillation after acute coronary syndromes or percutaneous intervention. Journal of the American College of Cardiology. 2022; 79(5): 417–27. DOI: 10.1016/j.jacc.2021.11.035
- Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, et al. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention. Insights from the AUGUSTUS trial. Circulation. 2019; 140: 1921–32. DOI: 10.1161/CIRCULATIONAHA.119.043308
- Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, et al. Cardiovascular implications of the COVID-19 pandemic: A global perspective. Can J Cardiol. 2020; 36(7): 1068–80. DOI: 10.1016/j.cjca.2020.05.018
- Volpe M, Gallo G. Atrial fibrillation and ischemic heart disease: Should we use acetylsalicylic acid beside anticoagulants? Eur Heart J Suppl. 2020; 22(Suppl L): L166–9. DOI: 10.1093/eurheartj/suaa159
DOI: https://doi.org/10.5334/gh.1312 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 19, 2022
Accepted on: Feb 21, 2024
Published on: Mar 12, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2024 Ayman Hammoudeh, Yahya Badaineh, Ramzi Tabbalat, Anas Ahmad, Mohammad Bahhour, Darya Ja’ara, Joud Shehadeh, Mohammad A. Jum’ah, Afnan Migdad, Mohammad Hani, Imad A. Alhaddad, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.